Long-term efficacy of nucleoside monotherapy in preventing HBV infection in HBsAg-negative recipients of anti-HBc-positive donor livers

Hepatology International

Volumn 4, Issue 4, 2010, Pages 707-715

  Chotiyaputta, Watcharasak ^a   Pelletier, Shawn J ^b   Fontana, Robert J ^a   Lok, Anna S F ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Entecavir; HBV infection; HBV vaccine; Hepatitis B immune globulin; Lamivudine

Indexed keywords

BASILIXIMAB; CYCLOSPORIN; ENTECAVIR; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; LAMIVUDINE; MEPREDNISONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NUCLEOSIDE DERIVATIVE; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY TITER; ARTICLE; BILIARY CIRRHOSIS; CAUCASIAN; CLINICAL ARTICLE; DRUG EFFICACY; DRUG PULSE THERAPY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSFUNCTION; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAINTENANCE THERAPY; MALE; METABOLIC ACIDOSIS; MONOTHERAPY; MYOPATHY; NEUROPATHY; NONALCOHOLIC FATTY LIVER; ORGAN DONOR; OUTCOME ASSESSMENT; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCLEROSING CHOLANGITIS; SEROCONVERSION;

EID: 78649453495     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-010-9188-0     Document Type: Article

References (27)

1. RC Dickson JE Everhart JR Lake Y Wei EC Seaberg RH Wiesner, et al. 1997 Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database Gastroenterology 113 1668 1674 1:STN:280:DyaK1c%2Fht12hsg%3D%3D 10.1053/gast.1997.v113.pm9352871 9352871 (Pubitemid 27461255)
2. ME Wachs WJ Amend NL Ascher PN Bretan J Emond JR Lake, et al. 1995 The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors Transplantation 59 230 234 1:STN:280:DyaK2M7ktFerug%3D%3D 7839446
3. SF Dodson S Issa V Araya T Gayowski A Pinna B Eghtesad, et al. 1997 Infectivity of hepatic allografts with antibodies to hepatitis B virus Transplantation 64 1582 1584 1:STN:280:DyaK1c%2Fns1SnsA%3D%3D 10.1097/00007890-199712150-00013 9415560 (Pubitemid 28047387)
4. DD Douglas J Rakela TL Wright RA Krom RH Wiesner 1997 The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient Liver Transpl Surg 3 105 111 1:STN:280: DyaK1c%2FgtlensA%3D%3D 10.1002/lt.500030202 9346723
5. KH Lee CT Wai SG Lim K Manjit HL Lee M Da Costa, et al. 2001 Risk for de novo hepatitis B from antibody to hepatitis B core antigen-positive donors in liver transplantation in Singapore Liver Transpl 7 469 470 1:STN:280: DC%2BD3MvjsFOrsQ%3D%3D 10.1002/lt.500070514 11349271
6. YS Chen CC Wang VH de Villa SH Wang YF Cheng TL Huang, et al. 2002 Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors Clin Transpl 16 405 409 10.1034/j.1399-0012.2002.01133.x (Pubitemid 36004270)
7. D Donataccio F Roggen C De Reyck C Verbaandert M Bodeus J Lerut 2006 Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool Transpl Int 19 38 43 10.1111/j.1432-2277.2005. 00225.x 16359375
8. M Prieto MD Gomez M Berenguer J Cordoba JM Rayon M Pastor, et al. 2001 De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population Liver Transpl 7 51 58 1:STN:280:DC%2BD3M7islCjtg%3D%3D 10.1053/jlts.2001.20786 11150423 (Pubitemid 32060915)
9. A Jain M Orloff P Abt R Kashyap R Mohanka K Lansing, et al. 2005 Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and lamivudine Transpl Proc 37 3187 3189 1:STN:280:DC%2BD2MrktVWitQ%3D%3D 10.1016/j.transproceed.2005.07.049 (Pubitemid 41435658)
10. E Fabrega C Garcia-Suarez A Guerra A Orive F Casafont J Crespo, et al. 2003 Liver transplantation with allografts from hepatitis B core antibody-positive donors: a new approach Liver Transpl 9 916 920 10.1053/jlts.2003.50190 12942452 (Pubitemid 37098839)
11. SF Dodson CA Bonham DA Geller TV Cacciarelli J Rakela JJ Fung 1999 Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors Transplantation 68 1058 1061 1:STN:280: DC%2BD3c%2FgtVemsA%3D%3D 10.1097/00007890-199910150-00028 10532552 (Pubitemid 29489337)
12. T Suehiro M Shimada K Kishikawa T Shimura Y Soejima T Yoshizumi, et al. 2005 Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation Liver Int 25 1169 1174 1:CAS:528:DC%2BD28XkslSrsg%3D%3D 10.1111/j.1478-3231.2005.01165.x 16343068 (Pubitemid 41782561)
13. D Holt R Thomas D Van Thiel JJ Brems 2002 Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation Arch Surg 137 572 575 1:CAS:528:DC%2BD38Xkt12ru7Y%3D 10.1001/archsurg.137.5.572 11982471
14. AS Yu JM Vierling SD Colquhoun WS Arnaout CK Chan E Khanafshar, et al. 2001 Transmission of hepatitis B infection from hepatitis B core antibody-positive liver allografts is prevented by lamivudine therapy Liver Transpl 7 513 517 1:STN:280:DC%2BD3MzoslGjsQ%3D%3D 10.1053/jlts.2001.23911 11443579 (Pubitemid 32547266)
15. E Prakoso SI Strasser DJ Koorey D Verran GW McCaughan 2006 Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors Clin Transpl 20 369 373 10.1111/j.1399-0012. 2006.00495.x (Pubitemid 43880574)
16. JR Nery C Nery-Avila KR Reddy R Cirocco D Weppler DM Levi, et al. 2003 Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine Transplantation 75 1179 1186 1:CAS:528:DC%2BD3sXjt1alsbo%3D 10.1097/01.TP.0000065283.98275.FE 12717200 (Pubitemid 36513018)
17. A Celebi Kobak Z Karasu M Kilic T Ozacar F Tekin F Gunsar, et al. 2007 Living donor liver transplantation from hepatitis B core antibody positive donors Transpl Proc 39 1488 1490 1:STN:280:DC%2BD2szmsFKguw%3D%3D 10.1016/j.transproceed.2006.11.015 (Pubitemid 46907879)
18. JR Nery R Gedaly R Vianna M Berho D Weppler D Levi, et al. 2001 Are liver grafts from hepatitis B surface antigen negative/anti-hepatitis B core antibody positive donors suitable for transplantation? Transpl Proc 33 1521 1522 1:STN:280:DC%2BD3M7mvV2muw%3D%3D 10.1016/S0041-1345(00)02580-X (Pubitemid 32237958)
19. AS Lok CL Lai N Leung GB Yao ZY Cui ER Schiff, et al. 2003 Long-term safety of lamivudine treatment in patients with chronic hepatitis B Gastroenterology 125 1714 1722 1:CAS:528:DC%2BD2cXhtVOrug%3D%3D 10.1053/j.gastro.2003.09.033 14724824 (Pubitemid 37500436)
20. RD Yen H Bonatti J Mendez J Aranda-Michel R Satyanarayana RC Dickson 2006 Case report of lamivudine-resistant hepatitis B virus infection post liver transplantation from a hepatitis B core antibody donor Am J Transpl 6 1077 1083 1:STN:280:DC%2BD283gsVOjsA%3D%3D 10.1111/j.1600-6143.2006.01313.x (Pubitemid 44356661)
21. R Perrillo 2009 Hepatitis B virus prevention strategies for antibody to hepatitis B core antigen-positive liver donation: a survey of North American, European, and Asian-Pacific transplant programs Liver Transpl 15 223 232 10.1002/lt.21675 19177436
22. J Rosenau N Hooman J Hadem K Rifai MJ Bahr G Philipp, et al. 2007 Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation Liver Transpl 13 367 373 10.1002/lt.21003 17318859 (Pubitemid 46444465)
23. CM Lo CL Liu SC Chan GK Lau ST Fan 2005 Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B J Hepatol 43 283 287 1:CAS:528:DC%2BD2MXlvFals7c%3D 10.1016/j.jhep.2005.03.013 15964658 (Pubitemid 40956881)
24. M Angelico D Di Paolo MO Trinito A Petrolati A Araco S Zazza, et al. 2002 Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis Hepatology 35 176 181 10.1053/jhep.2002.30278 11786974 (Pubitemid 34032558)
25. R Barcena G Moraleda J Moreno MD Martin E de Vicente J Nuno, et al. 2006 Prevention of de novo HBV infection by the presence of anti-HBs in transplanted patients receiving core antibody-positive livers World J Gastroenterol 12 2070 2074 16610059
26. C Manzarbeitia DJ Reich JA Ortiz KD Rothstein VR Araya SJ Munoz 2002 Safe use of livers from donors with positive hepatitis B core antibody Liver Transpl 8 556 561 10.1053/jlts.2002.33451 12037788 (Pubitemid 34619089)
27. CM Lange J Bojunga WP Hofmann K Wunder U Mihm S Zeuzem, et al. 2009 Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function Hepatology 50 2001 2006 1:CAS:528:DC%2BD1MXhs1SjurnN 10.1002/hep.23346 19937695